In a study conducted by the European Prostate Cancer Screening Trial low risk tumors (PSA < 10 ng/mL and Gleason score ≤ 6) were almost three times more common in the screened group than the control group [47,48]. The gene discussed is KLK3; the disease is prostate carcinoma.